Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
Fig. 7 B
Yang J et al. (2020)
|
Xla Wt + xbp1 + DEX
NF42 (immunohistochemistry)
|
|
|
|
Fig. 7 A
Yang J et al. (2020)
|
Xla Wt + xbp1 + DEX
NF42 (in situ hybridization)
|
|
|
|
Fig. 4. AB
Yang J et al. (2020)
|
Xla Wt + xbp1 MO
NF42 (immunohistochemistry)
|
|
|
|
Fig. 4 B, D
Yuan L et al. (2014)
|
Xla Wt + ern1 MO
NF 43
|
|
|
|
Fig 7 B D
Yuan L et al. (2014)
|
Xla Wt + xbp1 MO
NF 43
|
|
|
|
Fig 3f
Oropeza D and Horb M (2012)
|
Xla Wt + Hsa.neurog3-GR + DEX
NF44 (in situ hybridization)
|
|
|
|
Fig 3b
Oropeza D and Horb M (2012)
|
Xla Wt + Mmu.neurog3-GR + DEX
NF44 (in situ hybridization)
|
|
|
|
Fig 4 e
Oropeza D and Horb M (2012)
|
Xla Wt + neurog3-GR + DEX
NF28 (in situ hybridization)
|
|
|
|
Fig 4 f
Oropeza D and Horb M (2012)
|
Xla Wt + neurog3-GR + DEX
NF32 (in situ hybridization)
|
|
|
|
Fig 4 g
Oropeza D and Horb M (2012)
|
Xla Wt + neurog3-GR + DEX
NF32 (in situ hybridization)
|
|
|